Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation

PURPOSE: Recurrently mutated genes in myelodysplastic syndrome (MDS) are pathogenic drivers and powerfully associated with clinical phenotype and prognosis. Whether these types of mutations predict outcome after allogeneic hematopoietic stem-cell transplantation (HSCT) in patients with MDS is not kn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bejar, Rafael, Stevenson, Kristen E., Caughey, Bennett, Lindsley, R. Coleman, Mar, Brenton G., Stojanov, Petar, Getz, Gad, Steensma, David P., Ritz, Jerome, Soiffer, Robert, Antin, Joseph H., Alyea, Edwin, Armand, Philippe, Ho, Vincent, Koreth, John, Neuberg, Donna, Cutler, Corey S., Ebert, Benjamin L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4207878/
https://ncbi.nlm.nih.gov/pubmed/25092778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.52.3381
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados